The expression of the main four factors (hENT1, dCK, RRM1 and RRM2) involved in gemcitabine transport and metabolism was also shown to correlate with acquired resistance to gemcitabine in pancreatic cancer cells [35]. This evidence concerns the gene RRM2 and familial pancreatic carcinoma.